Search
Showing results for "Childhood interstitial lung disease "
Adam Dan Francesca Susan Saddler Weiss Sanna Rumisha PhD PhD Dr PhD (Biostatistics) Senior Research Officer Honorary Research Fellow Research
Collecting DNA samples from Australian families affected by diabetes.
Contact us If you'd like to get in touch, please contact us by phone or email. Phone: 0400 450 240 Email: vtg@thekids.org.au PAEDS Paediatric Active
Nonalcoholic fatty liver disease (NAFLD) and its metabolic risk factors are recognized during childhood and adolescence.
Nonalcoholic fatty liver disease and its metabolic risk factors are recognized during childhood and adolescence.
This large population-based study suggests a significant healthcare burden associated with influenza in children with a range of chronic lung diseases
The Global Disease Modelling group informs development and implementation of drugs, medical treatments and non-medical interventions to effectively tackle disease. They build mathematical models of diseases, designed to take into account the complex constellation of interactions between pathogens, humans, diseases, the environment and entire healthcare systems.
Addressing the recognized challenges and inequalities in providing high quality healthcare for rare diseases such as children's interstitial lung disease (chILD) requires collaboration across institutional, geographical, discipline, and system boundaries. The Children's Interstitial Lung Disease Respiratory Network of Australia and New Zealand (chILDRANZ) is an example of a clinical network that brings together multidisciplinary health professionals for collaboration, peer learning, and advocacy with the goal of improving the diagnosis and management of this group of rare and ultra-rare conditions.
Pat Deborah Holt Strickland PhD, DSc, FRCPath, FRCPI, FAA PhD Emeritus Honorary Researcher Head, Pregnancy and Early Life Immunology Patrick.Holt@
Our findings demonstrate the utility of unsupervised analysis in elucidating heterogeneity in asthma pathogenesis